Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
70
# OF OVERLAPPING
HOLDINGS
IBB
252
HOLDINGS
32%
ALSO IN SBIO
SBIO
94
HOLDINGS
82%
ALSO IN IBB
SECTOR DRIFT (IBB minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
RHYTHM PHARMACEUTICALS, INC. | 0.6% | 3.6% | 0.6% |
|
AVIDITY BIOSCIENCES INC | 0.6% | 3.5% | 0.6% |
 |
ALKERMES PLC | 0.5% | 2.7% | 0.5% |
|
AXSOME THERAPEUTICS, INC. | 0.5% | 3.2% | 0.5% |
|
ACADIA PHARMACEUTICALS INC | 0.5% | 2.6% | 0.5% |
IBB Overweight Relative to SBIO
|
GILEAD SCIENCES INC | 8.1% |
|
AMGEN INC | 7.5% |
|
REGENERON PHARMACEUTICALS | 6.7% |
|
ALNYLAM PHARMACEUTICALS INC | 6.2% |
|
VERTEX PHARMACEUTICALS INC | 6.2% |
|
IQVIA HOLDINGS INC | 3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.0% |
 |
ARGENX SE ADR | 2.9% |
|
NATERA INC | 2.2% |
|
INSMED INC | 2.2% |
IBB Underweight Relative to SBIO
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
AVIDITY BIOSCIENCES INC | -2.9% |
|
AXSOME THERAPEUTICS, INC. | -2.7% |
|
NUVALENT, INC. CLASS A | -2.7% |
|
VIKING THERAPEUTICS, INC. | -2.6% |
 |
MERUS N.V. | -2.5% |
|
ALKERMES PLC | -2.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
ARCELLX, INC. | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |